{"id":48542,"date":"2022-09-19T16:01:49","date_gmt":"2022-09-19T14:01:49","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\/"},"modified":"2022-09-19T16:01:49","modified_gmt":"2022-09-19T14:01:49","slug":"global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\/","title":{"rendered":"Global Influenza Diagnostics Market Report 2022: Introduction of CLIA-waived POC Molecular Influenza Tests Presents Opportunities &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5647820\/influenza-diagnostics-market-global-industry?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=cbcfnv&amp;utm_campaign=1751651+-+Global+Influenza+Diagnostics+Market+Report+2022%3A++Introduction+of+CLIA-waived+POC+Molecular+Influenza+Tests+Presents+Opportunities&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Influenza Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220919005577\/en\/1575730\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220919005577\/en\/1575730\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global influenza diagnostics market size reached US$ 828.8 Million in 2021. Looking forward, the publisher expects the market to reach US$ 1,237.54 Million by 2027, exhibiting a CAGR of 6.91% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.\n<\/p>\n<p>\n<strong>Influenza Diagnostics Market Trends:<\/strong>\n<\/p>\n<p>\nThe elevating prevalence of several chronic diseases, such as asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic fibrosis, etc., that increase the risk of influenza, is primarily driving the global influenza diagnostics market. Besides this, the expanding geriatric population, who are more prone to respiratory tract infections, is also catalyzing the market growth. Additionally, the rising availability of advanced diagnostic immunoassay formats along with the growing usage of miniaturized devices in influenza diagnostics is positively influencing the global market.\n<\/p>\n<p>\nMoreover, the introduction of CLIA-waived POC molecular influenza tests and the shifting consumer preferences from centralized laboratories to decentralized point-of-care testing are also augmenting the market growth. In addition to this, the emerging popularity of rapid influenza diagnostic test (RIDT) that are convenient to use and provide results in approximately fifteen minutes is acting as a significant growth-inducing factor.\n<\/p>\n<p>\nFurthermore, various initiatives by WHO to strengthen influenza surveillance, monitoring, and data utilization, are also stimulating the market growth. In line with this, numerous government bodies are becoming more actively involved in taking preventative steps to reduce the risk of influenza. For instance, the U.S. CDC and the South-East Asian Region (SEAR) have collaborated to support non-researched bilateral influenza as a response to avian, seasonal, and pandemic influenza. In the coming years, the growing integration of artificial intelligence (AI) in influenza diagnostics to minimize the timelines for sample processing and facilitate error-free results is expected to drive the global influenza diagnostics market.\n<\/p>\n<p>\n<strong>Key Market Segmentation:<\/strong>\n<\/p>\n<p>\nThe publisher provides an analysis of the key trends in each sub-segment of the global influenza diagnostics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, test type, type of flu and end user.\n<\/p>\n<p>\n<strong>Breakup by Product:<\/strong>\n<\/p>\n<ul>\n<li>\nTest Kit and Reagents\n<\/li>\n<li>\nInstruments\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n<strong>Breakup by Test Type:<\/strong>\n<\/p>\n<ul>\n<li>\nMolecular Diagnostic Tests\n<\/li>\n<li>\nPolymerase Chain Reaction\n<\/li>\n<li>\nIsothermal Nucleic Acid Amplification Tests\n<\/li>\n<li>\nOther Molecular Tests\n<\/li>\n<li>\nTraditional Diagnostic Tests\n<\/li>\n<li>\nRapid Influenza Diagnostic Tests\n<\/li>\n<li>\nViral Culture Tests\n<\/li>\n<li>\nDirect Fluorescent Antibody Test\n<\/li>\n<li>\nSerological Tests\n<\/li>\n<\/ul>\n<p>\n<strong>Breakup by Type of Flu:<\/strong>\n<\/p>\n<ul>\n<li>\nType A Flu\n<\/li>\n<li>\nType B Flu\n<\/li>\n<li>\nType C Flu\n<\/li>\n<\/ul>\n<p>\n<strong>Breakup by End User:<\/strong>\n<\/p>\n<ul>\n<li>\nHospitals\n<\/li>\n<li>\nDiagnostic Laboratories\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n<strong>Breakup by Region:<\/strong>\n<\/p>\n<ul>\n<li>\nNorth America\n<\/li>\n<li>\nUnited States\n<\/li>\n<li>\nCanada\n<\/li>\n<li>\nAsia-Pacific\n<\/li>\n<li>\nChina\n<\/li>\n<li>\nJapan\n<\/li>\n<li>\nIndia\n<\/li>\n<li>\nSouth Korea\n<\/li>\n<li>\nAustralia\n<\/li>\n<li>\nIndonesia\n<\/li>\n<li>\nOthers\n<\/li>\n<li>\nEurope\n<\/li>\n<li>\nGermany\n<\/li>\n<li>\nFrance\n<\/li>\n<li>\nUnited Kingdom\n<\/li>\n<li>\nItaly\n<\/li>\n<li>\nSpain\n<\/li>\n<li>\nRussia\n<\/li>\n<li>\nOthers\n<\/li>\n<li>\nLatin America\n<\/li>\n<li>\nBrazil\n<\/li>\n<li>\nMexico\n<\/li>\n<li>\nOthers\n<\/li>\n<li>\nMiddle East and Africa\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1 Preface<\/strong>\n<\/p>\n<p>\n<strong>2 Scope and Methodology<\/strong>\n<\/p>\n<p>\n<strong>3 Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>4 Introduction<\/strong>\n<\/p>\n<p>\n<strong>5 Global Influenza Diagnostics Market<\/strong>\n<\/p>\n<p>\n<strong>6 Market Breakup by Product<\/strong>\n<\/p>\n<p>\n<strong>7 Market Breakup by Test Type<\/strong>\n<\/p>\n<p>\n<strong>8 Market Breakup by Type of Flu<\/strong>\n<\/p>\n<p>\n<strong>9 Market Breakup by End User<\/strong>\n<\/p>\n<p>\n<strong>10 Market Breakup by Region<\/strong>\n<\/p>\n<p>\n<strong>11 SWOT Analysis<\/strong>\n<\/p>\n<p>\n<strong>12 Value Chain Analysis<\/strong>\n<\/p>\n<p>\n<strong>13 Porters Five Forces Analysis<\/strong>\n<\/p>\n<p>\n<strong>14 Price Analysis<\/strong>\n<\/p>\n<p>\n<strong>15 Competitive Landscape<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAbbott Laboratories\n<\/li>\n<li>\nBecton Dickinson and Company\n<\/li>\n<li>\nCoris Bioconcept\n<\/li>\n<li>\nDanaher Corporation\n<\/li>\n<li>\nDiaSorin S.p.A.\n<\/li>\n<li>\nF. Hoffmann-La Roche Ltd (Roche Holding AG)\n<\/li>\n<li>\nHologic Inc.\n<\/li>\n<li>\nMeridian Bioscience Inc.\n<\/li>\n<li>\nQiagen N.V\n<\/li>\n<li>\nQuidel Corporation\n<\/li>\n<li>\nSekisui Diagnostics LLC (Sekisui Medical Co. Ltd.)\n<\/li>\n<li>\nSiemens Healthineers AG (Siemens AG).\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5647820\/influenza-diagnostics-market-global-industry?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=cbcfnv&amp;utm_campaign=1751651+-+Global+Influenza+Diagnostics+Market+Report+2022%3A++Introduction+of+CLIA-waived+POC+Molecular+Influenza+Tests+Presents+Opportunities&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/pttoy2<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#97;&#x69;l&#116;&#x6f;&#x3a;p&#114;&#x65;&#x73;s&#64;&#x72;&#x65;s&#101;&#x61;&#x72;c&#104;&#x61;&#x6e;d&#109;&#x61;r&#107;&#101;&#x74;s&#46;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#x65;&#x73;&#x73;&#x40;&#x72;&#x65;&#x73;&#x65;&#x61;&#x72;&#x63;&#x68;&#x61;&#x6e;&#x64;&#x6d;&#x61;&#x72;&#x6b;&#x65;&#x74;&#x73;&#x2e;&#x63;&#x6f;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Influenza Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global influenza diagnostics market size reached US$ 828.8 Million in 2021. Looking forward, the publisher expects the market to reach US$ 1,237.54 Million by 2027, exhibiting a CAGR of 6.91% during 2021-2027. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48542","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Influenza Diagnostics Market Report 2022: Introduction of CLIA-waived POC Molecular Influenza Tests Presents Opportunities - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Influenza Diagnostics Market Report 2022: Introduction of CLIA-waived POC Molecular Influenza Tests Presents Opportunities - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Influenza Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global influenza diagnostics market size reached US$ 828.8 Million in 2021. Looking forward, the publisher expects the market to reach US$ 1,237.54 Million by 2027, exhibiting a CAGR of 6.91% during 2021-2027. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-19T14:01:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220919005577\/en\/1575730\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Influenza Diagnostics Market Report 2022: Introduction of CLIA-waived POC Molecular Influenza Tests Presents Opportunities &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-09-19T14:01:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\\\/\"},\"wordCount\":655,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220919005577\\\/en\\\/1575730\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\\\/\",\"name\":\"Global Influenza Diagnostics Market Report 2022: Introduction of CLIA-waived POC Molecular Influenza Tests Presents Opportunities - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220919005577\\\/en\\\/1575730\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-09-19T14:01:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220919005577\\\/en\\\/1575730\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220919005577\\\/en\\\/1575730\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Influenza Diagnostics Market Report 2022: Introduction of CLIA-waived POC Molecular Influenza Tests Presents Opportunities &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Influenza Diagnostics Market Report 2022: Introduction of CLIA-waived POC Molecular Influenza Tests Presents Opportunities - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Influenza Diagnostics Market Report 2022: Introduction of CLIA-waived POC Molecular Influenza Tests Presents Opportunities - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Influenza Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global influenza diagnostics market size reached US$ 828.8 Million in 2021. Looking forward, the publisher expects the market to reach US$ 1,237.54 Million by 2027, exhibiting a CAGR of 6.91% during 2021-2027. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-19T14:01:49+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220919005577\/en\/1575730\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Influenza Diagnostics Market Report 2022: Introduction of CLIA-waived POC Molecular Influenza Tests Presents Opportunities &#8211; ResearchAndMarkets.com","datePublished":"2022-09-19T14:01:49+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\/"},"wordCount":655,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220919005577\/en\/1575730\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\/","name":"Global Influenza Diagnostics Market Report 2022: Introduction of CLIA-waived POC Molecular Influenza Tests Presents Opportunities - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220919005577\/en\/1575730\/21\/logo.jpg","datePublished":"2022-09-19T14:01:49+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220919005577\/en\/1575730\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220919005577\/en\/1575730\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-influenza-diagnostics-market-report-2022-introduction-of-clia-waived-poc-molecular-influenza-tests-presents-opportunities-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Influenza Diagnostics Market Report 2022: Introduction of CLIA-waived POC Molecular Influenza Tests Presents Opportunities &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48542"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48542\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48542"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}